Tramedico introduces Idroflog, a new eye drop for the treatment of dry eye. Idroflog is available without a prescription.
Idroflog contains 0.2% hyaluronic acid and 0.001% hydrocortisone. The eye drops have been developed for use in patients with dry eye and represent a new addition to Tramedico’s eye care portfolio.
With the introduction of Idroflog, Tramedico offers a new option for patients experiencing symptoms of dry eye.
Broomfenac Rafarm is now available from Tramedico. This prescription eye drop is indicated for the treatment of postoperative ocular inflammation following cataract extraction in adults, further expanding Tramedico’s ophthalmic portfolio.
Tramedico is proud to introduce AYZ Matrix3® — an advanced new eye drop, now part of the AYZ range.
In 2025, Tramedico is again using its annual donation to create impact beyond “a nice gesture.” We purposefully choose initiatives where our support is put to work immediately and leads to clear, measurable outcomes—so it’s never just a drop in the ocean.
